genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Restless legs syndrome
Industry News
Dr. Reddy’s Acquires U.S. Rights to XenoPort’s Phase III Psoriasis Candidate
GEN Staff Writer
-
March 28, 2016
0
News
XenoPort and GSK End Horizant Collaboration
GEN Staff Writer
-
November 8, 2012
0
Drug Discovery
FDA Approves XenoPort, GSK’s Horizant for Managing Postherpetic Neuralgia
GEN Staff Writer
-
June 7, 2012
0
News
Impax and GSK Report Positive Data from Third Phase III Study with Parkinson Disease Drug
GEN Staff Writer
-
August 15, 2011
0
News
XenoPort and GSK’s Treatment for Restless Legs Syndrome Cleared in the U.S.
GEN Staff Writer
-
April 7, 2011
0
News
Omeros Adds Addiction and Compulsive Disorders to License Agreement with Daiichi
GEN Staff Writer
-
February 22, 2011
0
News
Astellas and XenoPort Submit Japanese Filing for RLS Therapy
GEN Staff Writer
-
November 19, 2009
0
News
XenoPort Opts into Co-Promotion Deal with GSK for RLS Drug
GEN Staff Writer
-
April 13, 2009
0
News
GSK and XenoPort Are Temporarily Withdrawing Their RLS NDA
GEN Staff Writer
-
November 10, 2008
0
News
XenoPort Shares Spike on Successful Phase III RLS Trial
GEN Staff Writer
-
April 25, 2007
0
1
2
Page 1 of 2
Scroll Up
Scroll Up
